Rekha Hemrajani

ALXO

Rekha Hemrajani serves as Director at ALX Oncology Holdings Inc. (ALXO). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

1 trades

$46.4K

Total Sells

1 trades

$22.4K

Net Position

Net Buyer

$24.0K

Companies Traded

MXCT, ALXO

Active Period

Dec 2024 – Jun 2025

2 total trades

Most Recent

Sell MXCT

Jun 25, 2025 · $22.4K

Rekha Hemrajani's Insider Trading at ALX Oncology Holdings Inc. (ALXO)

Buys

1 · $46.4K

Sells

0 · $0.00

Total Shares Bought

30,000

Total Shares Sold

ALXO Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Dec 2, 2024↗	Buy	30,000	$1.55	$46.4K	0

Rekha Hemrajani's Insider Trading at MaxCyte, Inc. (MXCT)

Buys

0 · $0.00

Sells

1 · $22.4K

Total Shares Bought

Total Shares Sold

10,684

MXCT Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Jun 25, 2025↗	Sell	10,684	$2.09	$22.4K	0

Related Insiders

Shelly Pinto

officer: SVP, FINANCE AND CAO

ALXOSell · Feb 18, 2026

Shelly Pinto

SVP, FINANCE AND CAO

ALXOSell · Feb 18, 2026

Jason Lettmann

CHIEF EXECUTIVE OFFICER

ALXOSell · Feb 17, 2026

GOODMAN COREY S

director, 10 percent owner:

ALXOBuy · Feb 2, 2026

GOODMAN COREY S

Director

ALXOBuy · Feb 2, 2026

Harish Shantharam

Chief Financial Officer

ALXOBuy · Aug 18, 2025

Maher Masoud

President and CEO

MXCTBuy · Aug 13, 2025

Stanley C Erck

Director

MXCTBuy · Aug 13, 2025

Explore More Insider Trading Data

ALXO Insider Trading Activity

View all insider trades at ALX Oncology Holdings Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity